Semaglutide in Charlotte (2026)
The best ways to get Semaglutide in Charlotte, North Carolina. Compare 51 providers, compounded vs brand pricing, and local insurance.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Getting Semaglutide in Charlotte
Charlotte is sixteenth-largest city in the United States, located in North Carolina with a population of approximately 885,708. Telehealth is legal in North Carolina, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Charlotte ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.
Charlotte residents have access to both brand-name Semaglutide (Wegovy and Ozempic) and compounded Semaglutide formulations through licensed 503A compounding pharmacies[4]. Brand-name medication is typically priced around $1349/month without insurance[3], while compounded Semaglutide from telehealth providers averages around $195/month in North Carolina[1] — a savings of about $13,848 per year. Insurance coverage for anti-obesity GLP-1s in North Carolina varies by plan[5], and North Carolina's adult obesity rate is approximately 32.1%[2].
Best Semaglutide Providers Serving Charlotte
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
BetterMe Rx
Best for: patients who value pharmacy transparency — six named compounding partners
Editorial score · methodology
Calibrate Health
Best for: patients with insurance coverage who want a year-long coaching-wrap around branded Wegovy / Zepbound / Foundayo
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Curex
Best for: affordable compounded GLP-1 with strong corporate transparency and pharmacy testing
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Elara Health and Wellness
Best for: Patients seeking a physician-guided bundled-care GLP-1 program (medication + quarterly labs + physician visits + coaching + 24/7 messaging at a single monthly price) with maximum pharmacy-partner transparency (four named 503A pharmacies disclosed) and clear corporate accountability (JTE Medical, LLC named parent). Strong fit for buyers who want more than transactional Rx access but don't need the unlimited-primary-care scope of true DPC models.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Fresh Day Meds
Best for: Price-sensitive patients seeking the lowest-cost compounded semaglutide or tirzepatide from a LegitScript-certified, HIPAA-compliant multi-product telehealth platform with publicly disclosed Texas corporate headquarters, who don't require a named pharmacy partner or brand-name GLP-1 fallback.
Editorial score · methodology
Gimme Care
Best for: affordable compounded GLP-1 with nationwide coverage and microdose options
Editorial score · methodology
Editorial score · methodology
InstaRX
Best for: Patients in any of the 50 states or DC seeking a multi-product compounded-medication telehealth platform (GLP-1 + peptides + sexual health) where they prefer to complete an intake to see pricing rather than comparing public per-dose tiers. NOT recommended for patients who require transparent upfront pricing, named pharmacy-partner disclosure, or visible LegitScript/HIPAA accreditation before committing to an intake.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Maves (Homera Health)
Best for: Performance-oriented buyers (men's health + body optimization framing) seeking aggressive first-month pricing ($99/mo semaglutide intro) with a verifiable LegitScript ID, all-50-state coverage, and brand-plus-parent corporate disclosure (Maves under Homera Health). Strong fit for buyers who prioritize transparency signals (verifiable LegitScript ID + verbatim FDA disclaimer) over named pharmacy partners.
Editorial score · methodology
Editorial score · methodology
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Mint Med
Best for: Cost-sensitive buyers seeking flat $159/mo 'all doses' compounded GLP-1 pricing without per-tier escalation, with HSA/FSA payment + no-membership pay-as-you-go model + LegitScript verification + verbatim FDA disclaimer. Strong fit for self-pay patients in any of the 36 listed states who value pricing transparency + cancel-anytime over premium clinical features.
Editorial score · methodology
Nalena
Best for: Women seeking transparent low-entry-price ($149/mo) compounded semaglutide or tirzepatide on a GLP-1-only platform with no membership fees, no hidden costs, money-back guarantee, and free 2-day shipping. Not recommended for patients who require brand-name FDA-approved GLP-1s — Nalena is compounded-only.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
NiceRx
Best for: patients seeking batch-tested compounded GLP-1 with transparent entity disclosure
Editorial score · methodology
Editorial score · methodology
Ondra Health
Best for: Cost-sensitive patients who want the lowest compounded-GLP-1 monthly cost and are willing to commit quarterly.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
PlushCare
Best for: readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribing
Editorial score · methodology
Precision Telemed
Best for: transparent month-to-month compounded GLP-1 with pharmacy quality documentation
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Tyde Wellness
Best for: Cash-pay patients wanting transparent compounded-GLP-1 pricing with named, LegitScript-certified pharmacy fulfillment and the option to bundle menopause/HRT, hair loss, or longevity peptides through a single 50-state provider.
Editorial score · methodology
Editorial score · methodology
Vitara RX
Best for: Cost-sensitive patients seeking the lowest flat-rate compounded GLP-1 pricing from a LegitScript-certified marketplace with a named 503A pharmacy, who are comfortable with a marketplace model lacking a named medical director and a strict no-refunds policy.
Editorial score · methodology
Vytora Health
Best for: Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
Editorial score · methodology
Editorial score · methodology
Zealthy
Best for: not currently recommended — listed for transparency and reader awareness only
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Wegovy · Drugs and brands
- Ozempic · Drugs and brands
- Rybelsus · Drugs and brands
- GLP-1 receptor · Mechanism
- STEP-1 · Major trials
- SELECT · Major trials
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
Get Semaglutide Price Alerts in Charlotte
Be the first to know about new Semaglutide promos and providers in Charlotte.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
- 3.NovoCare — Wegovy cash-pay and savings program— Novo Nordisk (NovoCare).
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.